IRIS Accounts Production v24.3.0.553 07452401 Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false Fair value model Ordinary 1.00000 53963 50583 11879 16752 53963 13372 11879 53963 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074524012022-11-30074524012023-11-30074524012022-12-012023-11-30074524012021-11-30074524012021-12-012022-11-30074524012022-11-3007452401ns15:EnglandWales2022-12-012023-11-3007452401ns14:PoundSterling2022-12-012023-11-3007452401ns10:Director12022-12-012023-11-3007452401ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007452401ns10:SmallEntities2022-12-012023-11-3007452401ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3007452401ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007452401ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3007452401ns10:FullAccounts2022-12-012023-11-3007452401ns10:OrdinaryShareClass12022-12-012023-11-300745240142ns10:Director22022-11-300745240142ns10:Director22021-11-300745240142ns10:Director22022-12-012023-11-300745240142ns10:Director22021-12-012022-11-300745240142ns10:Director22023-11-300745240142ns10:Director22022-11-3007452401ns10:Director22022-12-012023-11-3007452401ns10:CompanySecretary12022-12-012023-11-3007452401ns10:RegisteredOffice2022-12-012023-11-3007452401ns5:CurrentFinancialInstruments2023-11-3007452401ns5:CurrentFinancialInstruments2022-11-3007452401ns5:Non-currentFinancialInstruments2023-11-3007452401ns5:Non-currentFinancialInstruments2022-11-3007452401ns5:ShareCapital2023-11-3007452401ns5:ShareCapital2022-11-3007452401ns5:FurtherSpecificReserve3ComponentTotalEquity2023-11-3007452401ns5:FurtherSpecificReserve3ComponentTotalEquity2022-11-3007452401ns5:RetainedEarningsAccumulatedLosses2023-11-3007452401ns5:RetainedEarningsAccumulatedLosses2022-11-3007452401ns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-12-012023-11-3007452401ns5:PlantMachinery2022-12-012023-11-3007452401ns5:ComputerEquipment2022-12-012023-11-3007452401ns5:LandBuildings2022-11-3007452401ns5:PlantMachinery2022-11-3007452401ns5:ComputerEquipment2022-11-3007452401ns5:LandBuildings2022-12-012023-11-3007452401ns5:LandBuildings2023-11-3007452401ns5:PlantMachinery2023-11-3007452401ns5:ComputerEquipment2023-11-3007452401ns5:LandBuildings2022-11-3007452401ns5:PlantMachinery2022-11-3007452401ns5:ComputerEquipment2022-11-3007452401ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3007452401ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-3007452401ns5:Secured2023-11-3007452401ns5:Secured2022-11-3007452401ns10:OrdinaryShareClass12023-11-30074524011ns10:Director12022-11-30074524011ns10:Director12021-11-30074524011ns10:Director12022-12-012023-11-30074524011ns10:Director12021-12-012022-11-30074524011ns10:Director12023-11-30074524011ns10:Director12022-11-30
REGISTERED NUMBER: 07452401 (England and Wales)















Lucas-Chave Dermatology Limited

Unaudited Financial Statements for the Year Ended 30 November 2023






Lucas-Chave Dermatology Limited (Registered number: 07452401)






Contents of the Financial Statements
for the year ended 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Lucas-Chave Dermatology Limited

Company Information
for the year ended 30 November 2023







DIRECTORS: T Chave
L Lucas-Chave





SECRETARY: L Lucas-Chave





REGISTERED OFFICE: One New Street
Wells
Somerset
BA5 2LA





REGISTERED NUMBER: 07452401 (England and Wales)





ACCOUNTANTS: Webb & Co Ltd
One New Street
Wells
Somerset
BA5 2LA

Lucas-Chave Dermatology Limited (Registered number: 07452401)

Balance Sheet
30 November 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 27,021 20,824
Investment property 5 575,000 575,000
602,021 595,824

CURRENT ASSETS
Debtors 6 49,330 99,624
Cash at bank 544,594 407,238
593,924 506,862
CREDITORS
Amounts falling due within one year 7 82,011 80,761
NET CURRENT ASSETS 511,913 426,101
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,113,934

1,021,925

CREDITORS
Amounts falling due after more than one
year

8

(148,780

)

(154,726

)

PROVISIONS FOR LIABILITIES (77,276 ) (75,671 )
NET ASSETS 887,878 791,528

CAPITAL AND RESERVES
Called up share capital 10 10 10
Fair value reserve 244,827 244,827
Retained earnings 643,041 546,691
SHAREHOLDERS' FUNDS 887,878 791,528

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lucas-Chave Dermatology Limited (Registered number: 07452401)

Balance Sheet - continued
30 November 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 November 2024 and were signed on its behalf by:





T Chave - Director


Lucas-Chave Dermatology Limited (Registered number: 07452401)

Notes to the Financial Statements
for the year ended 30 November 2023

1. STATUTORY INFORMATION

Lucas-Chave Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - No depreciation
Plant and machinery - 20% on cost
Computer equipment - 33% on cost

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Lucas-Chave Dermatology Limited (Registered number: 07452401)

Notes to the Financial Statements - continued
for the year ended 30 November 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Freehold Plant and Computer
property machinery equipment Totals
£    £    £    £   
COST
At 1 December 2022 20,599 - 1,829 22,428
Additions - 8,027 - 8,027
At 30 November 2023 20,599 8,027 1,829 30,455
DEPRECIATION
At 1 December 2022 - - 1,604 1,604
Charge for year - 1,605 225 1,830
At 30 November 2023 - 1,605 1,829 3,434
NET BOOK VALUE
At 30 November 2023 20,599 6,422 - 27,021
At 30 November 2022 20,599 - 225 20,824

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 December 2022
and 30 November 2023 575,000
NET BOOK VALUE
At 30 November 2023 575,000
At 30 November 2022 575,000

If investment properties had not been revalued they would have been included at the following historical cost: £254,502. Investment properties were revalued by the directors at 30 November 2023.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 25,207 30,417
Other debtors 24,123 69,207
49,330 99,624

Lucas-Chave Dermatology Limited (Registered number: 07452401)

Notes to the Financial Statements - continued
for the year ended 30 November 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 6,300 6,300
Taxation and social security 68,131 58,494
Other creditors 7,580 15,967
82,011 80,761

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 148,780 154,726

9. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 155,080 161,026

A fixed and floating charge covering all the property or undertakings of the company dated 3 November 2014.

Legal charge over the property known as Unit 26/27 Plymouth Road Industrial Estate, Tavistock, Devon, PL19 9QN, dated 28 February 2015.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
10 Ordinary £1 10 10

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2023 and 30 November 2022:

2023 2022
£    £   
T Chave and L Lucas-Chave
Balance outstanding at start of year 53,963 50,583
Amounts advanced 11,879 16,752
Amounts repaid (53,963 ) (13,372 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 11,879 53,963

Interest has been charged on the loan balance at HMRC rates.